Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Bruno Alexandre Quadros Gomes, João Paulo Bastos Silva, Camila Fernanda Rodrigues Romeiro, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 329

Showing 1-25 of 329 citing articles:

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
Klaudia Jomová, Renáta Raptová, Suliman Yousef Alomar, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 10, pp. 2499-2574
Open Access | Times Cited: 964
Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma
Kaio Murilo Monteiro Espíndola, Roseane Guimarães Ferreira, Luis Eduardo Mosquera Narvaez, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 474
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Li Zuo, Evan R. Prather, Mykola Stetskiv, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4472-4472
Open Access | Times Cited: 408
Hippocampus and its involvement in Alzheimer’s disease: a review
Y. Lakshmisha Rao, B Ganaraja, B.V. Murlimanju, et al.
3 Biotech (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 304
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Edward O. Olufunmilayo, Michelle B. Gerke-Duncan, R. M. Damian Holsinger
Antioxidants (2023) Vol. 12, Iss. 2, pp. 517-517
Open Access | Times Cited: 289
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Deepali Singh
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 248
Management of oxidative stress and other pathologies in Alzheimer’s disease
Miriama Šimunková, Saleh Alwasel, Ibrahim M. Alhazza, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 9, pp. 2491-2513
Open Access | Times Cited: 235
Mechanisms and roles of mitophagy in neurodegenerative diseases
Yan Wang, Na Liu, Bingwei Lu
CNS Neuroscience & Therapeutics (2019) Vol. 25, Iss. 7, pp. 859-875
Open Access | Times Cited: 196
Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
Ángara Zambrano, Matías Molt, Elena Uribe, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3374-3374
Open Access | Times Cited: 176
SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
R. Manjula, Kumari Anuja, Francisco J. Alcaı́n
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 142
Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
Estefanía de Gregorio, Anna Colell, Albert Morales, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3858-3858
Open Access | Times Cited: 141
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects
Pingal Pritam, Rahul Deka, Anuradha Bhardwaj, et al.
Biology (2022) Vol. 11, Iss. 2, pp. 212-212
Open Access | Times Cited: 111
Antioxidant Therapeutic Strategies in Neurodegenerative Diseases
Constanza Morén, Ruth Mary deSouza, Darly Milena Giraldo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9328-9328
Open Access | Times Cited: 75
Oxidative stress: A target to treat Alzheimer's disease and stroke
Seema Briyal, Amaresh K. Ranjan, Anil Gulati
Neurochemistry International (2023) Vol. 165, pp. 105509-105509
Closed Access | Times Cited: 52
SIRT1 and SIRT6: The role in aging-related diseases
Yuzi You, Wei Liang
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166815-166815
Open Access | Times Cited: 51
Resveratrol Activates Antioxidant Protective Mechanisms in Cellular Models of Alzheimer’s Disease Inflammation
Clara Bartra, Yi Yuan, Kristijan Vuraić, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 177-177
Open Access | Times Cited: 22
Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Ali Azargoonjahromi, Fatemeh Abutalebian
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Resveratrol—A Promising Therapeutic Agent with Problematic Properties
Lyubomira Radeva, Krassimira Yoncheva
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 134-134
Open Access | Times Cited: 3
Advancements in autophagy perturbations in Alzheimer’s disease: Molecular aspects and therapeutics
Rishika Dhapola, Sneha Kumari, Prajjwal Sharma, et al.
Brain Research (2025) Vol. 1851, pp. 149494-149494
Closed Access | Times Cited: 3
Protective effects of resveratrol against PM2.5-induced damage in hNSCs and its mitigation of PM2.5-induced mitochondrial dysfunction in a 3D scaffold system
Ming‐Chang Chiang, Christopher J.B. Nicol, Yuping Yang, et al.
Neuroscience (2025)
Closed Access | Times Cited: 2
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Seyed Zachariah Moradi, Saeideh Momtaz, Zahra Bayrami, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 139
Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease
Bruno Dutra Arbo, Corinne André‐Miral, Raif Gregorio Nasre-Nasser, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 121
Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer’s Disease
Gurjit Kaur Bhatti, Arubala P. Reddy, P. Hemachandra Reddy, et al.
Frontiers in Aging Neuroscience (2020) Vol. 11
Open Access | Times Cited: 117
Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease
Zhuo Qu, Jiachen Sun, Wannian Zhang, et al.
Free Radical Biology and Medicine (2020) Vol. 159, pp. 87-102
Closed Access | Times Cited: 104
SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of resveratrol against neurodevelopment damage by fluoride
Qian Zhao, Zhiyuan Tian, Guoyu Zhou, et al.
Theranostics (2020) Vol. 10, Iss. 11, pp. 4822-4838
Open Access | Times Cited: 100
Page 1 - Next Page

Scroll to top